Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Jingjing Lu
Observed name:
Lu, Jingjing
Institutions:
Shanghai Medical College of Fudan University,
Nantong University,
Fudan University,
Affiliated Hospital of Nantong University,
Zhongshan Hospital
Observed institutions:
Shanghai Medical College of Fudan University,
Nantong University,
Fudan University,
Affiliated Hospital of Nantong University,
Zhongshan Hospital
ORCID:
0000-0003-3831-5537
Observed ORCID:
0000-0003-3831-5537
OpenAlex ID:
A5000675429
tRNA ‐derived fragments: Unveiling new roles and molecular mechanisms in cancer progression
2024
·
Jingjing Lu
, Ping Zhu
, et al.
·
International Journal of Cancer
·
26
The novel tRNA-derived fragment, tiRNA-Met, inhibits the malignant progression of triple-negative breast cancer by regulating RANBP3L via a targeted interaction with SNRPA
2025
·
Jingjing Lu
, Yangbai Sun
, et al.
·
Cellular & Molecular Biology Letters
·
6
PDF
piR-hsa-35410 promotes triple-negative breast cancer progression via enhancing PFKL mediated glycolysis
2025
·
Xiufen Zhang
, Xue Wang
, et al.
·
Biochemical Pharmacology
·
4
PLAAT2 facilitates the development of pancreatic cancer and serves as a predictor of resistance to chemotherapy
2025
·
Qiyang Chen
, Ting Liang
, et al.
·
BMC Cancer
·
1
Retraction Note: ClC-2 knockdown prevents cerebrovascular remodeling via inhibition of the Wnt/β-catenin signaling pathway
2026
·
Jingjing Lu
, Feng Xu
, et al.
·
Cellular & Molecular Biology Letters
PDF
Show more works
View as search
Works count:
6
Citation count:
37
H-index:
3
I10-index:
1
Year
Topic
Type